Your session is about to expire
← Back to Search
NDPP Presessions for Prediabetes
N/A
Waitlist Available
Research Sponsored by Denver Health and Hospital Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial found that an innovative pre-session enhancement to the National Diabetes Prevention Program (NDPP) called Pre-NDPP was successful in doubling attendance and weight loss outcomes as compared to previous NDPP participants who did not receive a pre-session.
Who is the study for?
This trial is for Denver Health patients who have had prediabetes, gestational diabetes, or are at risk based on a screening tool. Participants must have a BMI of 25 or more (23 if Asian), and be able to communicate in English or Spanish. Those with diagnosed diabetes or pregnant women cannot join.Check my eligibility
What is being tested?
The study tests an enhancement to the National Diabetes Prevention Program called Pre-NDPP, which aims to improve attendance and weight loss outcomes among diverse low-income populations at risk for type 2 diabetes.See study design
What are the potential side effects?
Since this intervention involves educational sessions rather than medication, typical drug side effects are not expected. However, participants may experience lifestyle changes due to diet and exercise adjustments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Weight loss
Secondary outcome measures
Attendance
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Pre-NDPPExperimental Treatment2 Interventions
Presessions + usual care NDPP
Group II: Usual care NDPPActive Control1 Intervention
Usual care NDPP only
Find a Location
Who is running the clinical trial?
Denver Health and Hospital AuthorityLead Sponsor
101 Previous Clinical Trials
399,914 Total Patients Enrolled
University of Colorado, DenverOTHER
1,732 Previous Clinical Trials
2,143,100 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Only patients from Denver Health are eligible.I have been diagnosed with diabetes.You weigh more than what is considered healthy for your height.I have a history of prediabetes or gestational diabetes.
Research Study Groups:
This trial has the following groups:- Group 1: Pre-NDPP
- Group 2: Usual care NDPP
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research study still accepting participants?
"Contrary to what is listed on clinicaltrials.gov, this particular trial has ceased recruitment efforts. The official posting was made in August of 2019 and the last update occured at the end of November 2022. Fortunately, 2178 other medical trials are still accepting participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger